Epigenetics Market By Product (Kits, Reagent, Enzymes, Instruments and Bioinformatics Tools), By Technology (DNA Methylation, Histone Modification and Other), By Application (Cancer, Metabolic Diseases, Immune Diseases, Cardiovascular Diseases and Other) - Growth, Future Prospects and Competitive Analysis, 2018 – 2026

Published By: Brisk Insights | Published On: Sep 24, 2021

 

Epigenetics is a term referred to the study of long-term changes in gene expression, which may or may not be heritable, and do not involve the changes to the DNA sequence. It is estimated that epigenetics market will grow at a double digit CAGR over the forecast period from 2018 to 2026. Some major factors assisting the market growth are increasing awareness about epigenetics in different medical fields, growing funding for research and development activities and increasing prevalence of complex diseases such as cancer. Conversely, lack of widespread availability of skilled professionals and existence stringent regulatory framework governing the field of epigenetics and genetic research restrain the market growth. 

 

The global epigenetics market is classified on the basis of products, technologies and applications. Market estimation and forecast analysis for each of these classes for the period from 2016 to 2026 are included in this report study along with respective CAGRs during the forecast from 2018 to 2026. On the basis of product types, the epigenetics market is categorized as kits (ChiP-Seq Kits, whole-genome amplification kits, 5-HMC and 5-MC analysis kits and other epigenetics kits), reagent, enzymes (DNA-modifying enzymes, protein-modifying enzymes and RNA-modifying enzymes), instruments and bioinformatics tools. Based on applications, this market segmented as cancer, metabolic diseases, immune diseases, cardiovascular diseases and other applications. DNA methylation, histone modification and other techniques are the technologies studied in this report. 

 

The global epigenetics market report also studies the following regional markets:

 

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of MEA

 

Alongside the numeric data (market size and forecast), subjective informational sets and assessment tools are also incorporated in this report to cover in-depth analysis of general market circumstance and future projections. Information such as epigenetics market drivers, challenges and opportunities cover insights related to current trends in the global epigenetics market. Attractive investment proposition, company profiles and market positioning of key manufacturers provide insights on the competitive situation of the global epigenetics market. This report also presents company profiles segment which features key data related to the prominent players involved in epigenetics market.

 

Based on the product types, the global epigenetics market is segmented as follows:

 

  • Kits   
    • ChiP-Seq Kits
    • Whole-Genome Amplification Kits
    • 5-HMC and 5-MC Analysis Kits
    • Other Epigenetics Kits
  • Reagents
  • Enzymes
    • DNA-Modifying Enzymes
    • Protein-Modifying Enzymes
    • RNA-Modifying Enzymes
  • Instruments
  • Bioinformatics Tools

 

Epigenetics is the term referred to heritable changes in genetic modifications that do not involve changes in the primary DNA sequence; it plays important role in gene expression. Epigenetic changes are regular and naturally occurred however, several factors such as lifestyle, disease state, nutrition, age and environment etc. may lead to epigenetic changes. The global epigenetics market is expected to witness rewarding development over the forecast period owing to increasing importance of epigenetics to understand mechanisms of human development, aging and origins of different forms of diseases such as cancer, mental illness, heart disease and several others. Currently, the demand for kits is highest in market and will also undergo the fastest market growth over the forecast period primarily due to, continuous advancement in the nature and precision of kits, wide availability of robust, simple-to-use, and cost-efficient kits, and increasing adoption from research laboratories. Furthermore, enormous investments in R&D, increase in the prevalence of several life-threatening diseases and increased government funding for life science research are other factors propelling the growth of epigenetics kits market globally.

 

Based on the applications, the global epigenetics market is segmented as follows:

  • Cancer
  • Metabolic Diseases
  • Immune Diseases
  • Cardiovascular Diseases
  • Others

 

From the last few decades, the demand for epigenetics study in characterization of various diseases has increased in the field of drug discovery and life science research. Applicability of epigenetics study for complex diseases such as cancer, behavior plasticity, autoimmune diseases, neurodegenerative and psychological disorders, addiction etc. has considerably increased in the market. In 2017, cancer is the major revenue-generating segment in the global epigenetics market because the reported evidence that epigenetic modifications have a considerable effect on cancer development and therefore management. Non-oncology segment of epigenetics market comprises metabolic diseases, infectious diseases, cardiovascular diseases, and others. Metabolic diseases was the largest share holding sub-segment in the year 2014 at over 32.0% due to the high impact of high-fat diet on DNA modifications and epigenetic regulation of metabolism.

 

However, the cardiovascular disorders segment is expected to be the fastest growing segment over the forecast period owing to the emergence of technologies such as microRNA modifications in diagnosis and treatment of cardiovascular disorders. Other factors such as increase in prevalence of different forms of cancer, strong product pipeline and higher number of unmet needs are fueling the growth epigenetics in cancer.

 

Based on the technology types, the global epigenetics market is segmented as follows:

 

  • DNA Methylation
  • Histone Modification
  • Other Techniques 

 

Epigenetics is the study of modification in gene expression that does not involve changes to the genetic code. The epigenetics market will grow significantly over the forecast period owing to its robustness. Furthermore, increasing applicability of epigenetics in targeted therapy and personalized medicine would influence the market growth over the forecast period. DNA methylation, non-coding RNA associated gene silencing and histone modification play an essential role in initiating and sustaining epigenetic changes. The introduction of technological advancement such as Methylation Sensitive PCR (MSP) and rapid adoption of these products to improve diagnostics efficiency are some factors attributing for its largest share. It is observed that the demand for DNA methylation technique was the highest in market as it is a rapid and accurate technique for whole genome analysis. DNA methylation technique is used in the preparation of DNA for methylation analysis; it includes the selection of methylated DNA, enzymatic compartmentalization by methylation sensitive enzymes, and biochemical treatment of the DNA. DNA methylation technique has great potential in understanding the functional mechanisms in complex disease and personalized drug development. Moreover, methylation plays a fundamental role in cell divisions, differentiation, apoptosis, growth factor response, detoxification, metastasis etc. that have promoted huge advances in the early detection of cancer. 

 

For the purpose of this study, the global epigenetics market is categorized as follows:

 

  • North America
    • United States
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

 

North America is the current geographical leader in the worldwide epigenetics market. Some key factors such as increase in demand for personalized medicines coupled with greater awareness between both patients and caregivers play a vital role in the dominance of this region. North America also houses some of the largest pharmaceuticals manufacturers which are actively involved in research and development of development of novel drugs in oncology and non-oncology treatments. Furthermore, some other factors such as well-developed healthcare infrastructure, rapid rise in popularity of epigenetics, higher prevalence of complex diseases and early acceptance of advanced technologies are fueling the market growth in North America. On the other hand, evolving regulatory policies in key counties such as China and India, growing research and development outsourcing and increasing population of patients with chronic diseases have a supportive role in the high market growth rate in Asia Pacific. Collaborations between domestic life science companies and international pharmaceuticals companies for the development of better therapeutics also facilitate the growth of this region.

 

Chapter 1. Preface


1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Phase III-Expert Panel Review
1.3.4. Assumptions

 

Chapter 2. Executive Summary


2.1. Global Epigenetics Market Portraiture
2.2. Global Epigenetics Market, by Product, 2017 (US$ Mn)
2.3. Global Epigenetics Market, by Technology, 2017 (US$ Mn)
2.4. Global Epigenetics Market, by Application, 2017 (US$ Mn)
2.5. Global Epigenetics Market, by Geography, 2017 (US$ Mn)

 

Chapter 3. Epigenetics: Market Dynamics and Outlook


3.1. Market Definition and Overview
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Challenges
3.2.3. Opportunities
3.3. Attractive Investment Proposition: Epigenetics Market, by Geography, 2017
3.4. Competitive Analysis of Key Players in Epigenetics Market, 2017

 

Chapter 4. Global Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)


4.1. Overview
4.2. Kits
4.2.1. ChiP-Seq Kits
4.2.2. Whole-Genome Amplification Kits
4.2.3. 5-HMC and 5-MC Analysis Kits
4.2.4. Other Epigenetics Kits
4.3. Reagents
4.4. Enzymes
4.4.1. DNA-Modifying Enzymes
4.4.2. Protein-Modifying Enzymes
4.4.3. RNA-Modifying Enzymes
4.5. Instruments
4.6. Bioinformatics Tools

 

Chapter 5. Global Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)


5.1. Overview
5.2. DNA Methylation
5.3. Histone Modification
5.4. Other Techniques

 

Chapter 6. Global Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)


6.1. Overview
6.2. Cancer
6.3. Metabolic Diseases
6.4. Immune Diseases
6.5. Cardiovascular Diseases
6.6. Others

 

Chapter 7. Global Epigenetics Market, by Geography, 2016 – 2026 (US$ Mn)


7.1. Overview
7.2. North America Epigenetics Market, 2016 – 2026 (US$ Mn)
7.2.1. North America Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
7.2.2. North America Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
7.2.3. North America Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
7.2.4. North America Epigenetics Market, by Country, 2016 – 2026 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe Epigenetics Market, 2016 – 2026 (US$ Mn)
7.3.1. Europe Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
7.3.2. Europe Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
7.3.3. Europe Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
7.3.4. Europe Epigenetics Market, by Country, 2016 – 2026 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific Epigenetics Market, 2016 – 2026 (US$ Mn)
7.4.1. Asia Pacific Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
7.4.2. Asia Pacific Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
7.4.3. Asia Pacific Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
7.4.4. Asia Pacific Epigenetics Market, by Country, 2016 – 2026 (US$ Mn)
7.4.4.1. China
7.4.4.2. Japan
7.4.4.3. Rest of APAC
7.5. Latin America Epigenetics Market, 2016 – 2026 (US$ Mn)
7.5.1. Latin America Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
7.5.2. Latin America Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
7.5.3. Latin America Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
7.5.4. Latin America Epigenetics Market, by Country, 2016 – 2026 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Epigenetics Market, 2016 – 2026 (US$ Mn)
7.6.1. Middle East and Africa Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
7.6.2. Middle East and Africa Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
7.6.3. Middle East and Africa Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
7.6.4. Middle East and Africa Epigenetics Market, by Region, 2016 – 2026 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

 

Chapter 8. Company Profiles


8.1. Abcam, Plc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Type Portfolio
8.1.4. Key Developments
8.2. Active Motif, Inc.
8.3. Agilent Technologies, Inc.
8.4. Bio-Rad Laboratories, Inc.
8.5. Diagenode, Inc.
8.6. Illumina, Inc.
8.7. Merck & Co., Inc.
8.8. New England Biolabs, Inc.
8.9. Perkinelmer, Inc.
8.10. Qiagen N.V.
8.11. Thermo Fisher Scientific, Inc.
8.12. Zymo Research Corp.

TABLE 1 Global Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 2 Global Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 3 Global Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 4 North America Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 5 North America Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 6 North America Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 7 North America Epigenetics Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 9 Europe Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 10 Europe Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 11 Europe Epigenetics Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 14 Asia Pacific Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 15 Asia Pacific Epigenetics Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 17 Latin America Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 18 Latin America Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 19 Latin America Epigenetics Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 20 Middle East and Africa Epigenetics Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 21 Middle East and Africa Epigenetics Market, by Technology, 2016 – 2026 (US$ Mn)
TABLE 22 Middle East and Africa Epigenetics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 23 Middle East and Africa Epigenetics Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 24 Abcam, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 25 Active Motif, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 26 Agilent Technologies, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 27 Bio-Rad Laboratories, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 28 Diagenode, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 29 Illumina, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 30 Merck & Co., Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 31 New England Biolabs, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 32 Perkinelmer, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 33 Qiagen N.V. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 34 Thermo Fisher Scientific, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)
TABLE 35 Zymo Research Corp. : Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Development)

FIG. 1 Epigenetics: Market Segmentation
FIG. 2 Global Epigenetics Market, by Product, 2017 (US$ Mn)
FIG. 3 Global Epigenetics Market, by Technology, 2017 (US$ Mn)
FIG. 4 Global Epigenetics Market, by Application, 2017 (US$ Mn)
FIG. 5 Global Epigenetics Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition, by Geography
FIG. 7 Market Competition Landscape, by Key Players, 2017
FIG. 8 Global ChiP-Seq Kits Market, 2016 – 2026 (US$ Mn)
FIG. 9 Global Whole-Genome Amplification Kits Market, 2016 – 2026 (US$ Mn)
FIG. 10 Global 5--HMC and 5-MC Analysis Kits Market, 2016 – 2026 (US$ Mn)
FIG. 11 Global Other Epigenetics Kits Market, 2016 – 2026 (US$ Mn)
FIG. 12 Global Reagents Market in Epigenetics, 2016 – 2026 (US$ Mn)
FIG. 13 Global DNA Modifying Enzymes Market in Epigenetics, 2016 – 2026 (US$ Mn)
FIG. 14 Global Protein Modifying Enzymes Market in Epigenetics, 2016 – 2026 (US$ Mn)
FIG. 15 Global RNA Modifying Enzymes Market in Epigenetics, 2016 – 2026 (US$ Mn)
FIG. 16 Global Instruments Market in Epigenetics, 2016 – 2026 (US$ Mn)
FIG. 17 Global Bioinformatics Tools Market in Epigenetics, 2016 – 2026 (US$ Mn)
FIG. 18 Global DNA Methylation Market in Epigenetics, 2016 – 2026 (US$ Mn)
FIG. 19 Global Histone Modification Market in Epigenetics, 2016 – 2026 (US$ Mn)
FIG. 20 Global Other Techniques Market for Epigenetics in Epigenetics, 2016 – 2026 (US$ Mn)
FIG. 21 Global Epigenetics Market for Cancer, 2016 – 2026 (US$ Mn)
FIG. 22 Global Epigenetics Market for Metabolic Diseases, 2016 – 2026 (US$ Mn)
FIG. 23 Global Epigenetics Market for Immune Diseases, 2016 – 2026 (US$ Mn)
FIG. 24 Global Epigenetics Market for Cardiovascular Diseases, 2016 – 2026 (US$ Mn)
FIG. 25 Global Epigenetics Market for Other Applications, 2016 – 2026 (US$ Mn)
FIG. 26 U.S. Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 27 Canada Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 28 U.K. Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 29 Germany Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 30 Rest of Europe Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 31 Japan Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 32 China Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 33 Rest of Asia Pacific Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 34 Brazil Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 35 Mexico Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 36 Rest of Latin America Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 37 GCC Epigenetics Market, 2016 – 2026 (US$ Mn)
FIG. 38 Rest of Middle East and Africa Epigenetics Market, 2016 – 2026 (US$ Mn)

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)